Empowering Precision Medicine for the Mind
That’s the promise of our approach—helping doctors objectively assess suicide risk, pain, stress, depression, and other mental health challenges, and match people to therapies that improve the quality and extend the duration of life. This results in the ability to do something unprecedented when treating mental illness: proceeding with confidence. We will also collaborate with pharmaceutical companies towards their new drug development, and that of our own repurposed drug candidates.
The Process

Relief from mental health suffering, in three stages.

The Hope

Now mental health management can benefit from the most potent treatment of all: clarity.

Nothing is more stressful than basing crucial health decisions on guesswork. / “Is this the wrong approach?” “Is it too much?” “Not enough?” / Until now, the only approach available was dependent on a patient’s self-report and a doctor’s clinical impression. But now mental health and pain can be treated with scientific rigor. / Quantified assessments, based on biomarker research. Confident therapeutics, tailored to each individual’s unique situation. Optimism based on reality, and hope based on quantifiable results. / A relief from suffering—addressing the cause of mental health problems, and the worry every solution is too imprecise. / “Wondering if you’re right” is its own kind of suffering. We’re here to end it.


Comprehensive approach. Implemented by an experienced team.

Alexander B. Niculescu, MD, PhD
Founder / Chairman / CEO

Dr. Niculescu developed the proprietary technologies licensed by the company. Trained as a researcher and clinician at the Scripps Research Institute and University of California at San Diego, he is currently a Professor of Psychiatry and Medical Neuroscience at Indiana University School of Medicine. He is also on the staff of the Veterans Hospital in Indianapolis, and completed an Executive MBA at IU Kelley School of Business. Dr. Niculescu is the recipient of prestigious national and international awards in the field of psychiatric genomics, and is internationally known for his work on precision medicine for mental health.

More about Dr. Niculescu's work. / LinkedIn
Tien Lee, MD
Co-Founder / Board Member

Dr. Lee is an experienced biotech business development executive; CEO of Aardvark Therapeutics; former CSO, NantKwest.

Erik Woods, PhD
Co-Founder / Advisor

Dr. Woods is an experienced entrepreneur. He is co-founder and CSO of Ossium Health.

Anantha Shekhar, MD, PhD
Co-Founder / Scientific Advisor

Dr. Shekhar is Associate Dean for Research, IU School of Medicine, and is the incoming Dean of the University of Pittsburgh School of Medicine. He is a world-class expert in neuropsychiatric drug development and clinical trials.

Richard Hake, PhD, JD
Co-Founder / Patent Counsel

Dr. Hake is chief patent counsel, Metagenics. He is formerly the chief patent counsel of Kythera Biopharmaceuticals.

Stephen M. Stahl, MD, PhD, DSc
Co-Founder / CMO

Dr. Stahl is Professor of Psychiatry, UC San Diego, and founder of the Neuroscience Education Institute. He is chairman of Arbor Scientia, and author of Stahl’s Psychopharmacology (3rd Ed., Cambridge University Press).

Scientific Advisory Board
Don Brown, MD, MS.
Scientific Advisor / Investor

Dr. Brown is currently Founder and CEO, Lifeomic. He is a serial entrepreneur (Genesys/Interactive Intelligence, Software Artistry), and a world-class expert in IT and databases.

Dr. Kim Janda
Scientific Advisor

Dr. Janda is a world-class chemist and professor at Scripps Research.

Jerold Chun, MD, PhD
Scientific Advisor

Dr. Chun is a leading neuroscientist and Professor at Sanford Burnham Prebys Institute, with extensive pharma drug discovery experience.

Mike Lardon, MD
Scientific Advisor

Dr. Lardon is a top sports psychiatrist in San Diego that works with top athletes and CEOs.

Sunil Kurian, PhD.
Chief Scientific Advisor

Transplant Genomics Inc., Scripps. Expert in blood biomarkers.

Jim Schulz, CPA
Chief Financial Advisor

Expert in financial management/operations for start-ups.

Shlomo Shemesh, MBA.
Chief Commercial Advisor

Caris Life Sciences. Expert in medical device, diagnostics, and pharma sales.

Felix Wyss, M.Sc.
Chief Informatics Advisor